Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function

This phase I, open-label, single-dose study evaluated the pharmacokinetics, safety, and tolerability of renally excreted drug dexpramipexole in subjects with normal and impaired renal function, i.e. mild, moderate, severe renal impairment, or end-stage renal disease (ESRD) requiring hemodialysis whe...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ping, Kerr, Doug, Marbury, Thomas, Ries, Daniel, Farwell, Wildon, Stecher, Scott, Dong, Yingwen, Wei, Dong, Rogge, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241030/
https://www.ncbi.nlm.nih.gov/pubmed/24965504
http://dx.doi.org/10.1002/jcph.353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241030/
https://www.ncbi.nlm.nih.gov/pubmed/24965504
http://dx.doi.org/10.1002/jcph.353

Ejemplares similares